In combination with the data in Figure 4C, these data suggest that JNK2 activation was most likely responsible for the IK11-induced death of HepG2 carcinoma cells, however, combined inhibition of JNK, Akt and ROS was necessary to completely protect against it. Here, MAPK9 is linked to carcinoma.